This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Özdemir, E. Articles by Yoshida, O. Search for Related Content PubMed Articles by Özdemir, E. Articles by Yoshida, O.

HLA-DRB1*0101 and *0405 as Protective Alleles in Japanese Patients with Renal Cell Carcinoma¹

Department of Urology, Faculty of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-01, Japan

A variety of malignancies have been linked to major histocompatibility complex genes, including the DRB1 alleles. The association of certain DRB1 antigens with renal cell carcinoma (RCC) has been both claimed and disclaimed. To determine whether HLA-DRB1 genotypes are associated with RCC, we used the modified PCR-RFLP method for the high-resolution HLA-DRB1 genotyping of 96 Japanese RCC patients. There were no significantly frequent HLA-DRB1 alleles, whereas the DRB1*0101 and *0405 alleles had significantly lower frequencies [P = 0.004, relative risk (RR) = 0.2 and P = 0.002, RR = 0.4) in the RCC patients than in the healthy Japanese controls (n = 1216). Moreover, patients with the HLA-DRB1*0101 or *0405 allele tended to be in earlier stages and to have less aggressive tumors than patients with neither of these alleles. The corresponding serotyping subclassification, however, showed a significantly lower frequency only for DRB1-DR1 (P = 0.01, RR = 0.3). High-resolution genotyping is essential because the polymorphism of the peptide-binding domain of major histocompatibility complex class II molecules is more precisely determined by genotypes than serotypes. In addition, inherent technical difficulties and potential typing errors render serotyping inefficient. Our data suggest that HLA-DRB1*0101 and *0405 are protective alleles for both RCC development and tumor progression.

¹ This work was supported in part by Grant-in-aid for Scientific Research 06671587 from the Ministry of Education, Science, Sports and Culture of Japan.

² To whom requests for reprints should be addressed. Phone: (075) 751-3325; Fax: (075) 761-3441.

Received 6/ 5/96. Accepted 12/18/96.

This article has been cited by other articles:

				E. Nakamura, Y. Megumi, T. Kobayashi, T. Kamoto, S. Ishitoya, T. Terachi, M. Tachibana, H. Matsushiro, T. Habuchi, Y. Kakehi, et al. Genetic Polymorphisms of the Interleukin-4 Receptor{alpha} Gene Are Associated with an Increasing Risk and a Poor Prognosis of Sporadic Renal Cell Carcinoma in a Japanese Population Clin. Cancer Res., August 1, 2002; 8(8): 2620 - 2625. [Abstract] [Full Text] [PDF]

				K. Haspolat, S. Günbey, and O. Derman A Randomized Trial of Granulocyte-Macrophage Colony-Stimulating Factor in Neonates With Sepsis and Neutropenia Pediatrics, January 1, 2001; 107(1): 36 - 41. [Abstract] [Full Text]

				Y. Nagaoka, H. Kabeya, M. Onuma, N. Kasai, K. Okada, and Y. Aida Ovine MHC Class II DRB1 Alleles Associated with Resistance or Susceptibility to Development of Bovine Leukemia Virus-induced Ovine Lymphoma Cancer Res., February 1, 1999; 59(4): 975 - 981. [Abstract] [Full Text] [PDF]